-The oxygen therapies market is predicted to reach $1.07 billion. New markets for oxygen therapies and advancement in delivery systems are expected to yield market momentum. The rise in the world's aging population and a demand for convenience for the home market are influencing factors. Industry leaders are AirSep Corporation, DeVilbiss Healthcare and Inovo, Inc. The U.S. and Europe are forecasted to have the highest growth.

-Medical facility lighting systems projections are expected to exceed $1.0 billion. Two factors drive growth in medical facility lighting: expansion of private sector hospitals and greater governmental resource allocations to developing nations. Advances include lighting systems free from thermal loading, progressive filtering to eliminate false coloring and enhanced reflection systems. Leading companies are BERCHTOLD Corporation; Burton Medical Products, Inc.; LXU Healthcare and Welch Allyn, Inc. The U.S., Europe and Japan lead the market, but Asia-Pacific and Latin America are emerging.


-Projected to reach approximately $275 million is the peptic ulcer testing market. Sanitation conditions in underdeveloped countries, the presence of helicobacter pylori, and widespread use of anti-inflammatory drugs drive market growth. Market leaders are Beckman Coulter, Inc., Kibion AB and Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. Latin America leads the market, with Asia-Pacific and the Middle East emerging.

Global Industry Analysts is a worldwide market intelligence and global business strategy source.

Back to HCB News

More Industry Headlines